MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Clinical calcium · 2012

[Progress in the treatment targeting intracellular signaling in the context of osteoimmunology].

Tanaka Yoshiya

Аннотация на английскомСтатьяОбзорПеревод пока не подготовлен

Аннотация

The appropriate intracellular signaling pathways are activated via binding of receptors on the cell surface to ligands such as cytokines and cell surface antigens. The tyrosine kinase transduce the first "outside to in" signals to be phosphorylated following receptor binding to its ligand. Among them, members of Janus kinase (Jak) family and Spleen tyrosine kinase (Syk) family are essential for the signaling pathways of various cytokines and are implicated in the pathogenesis of autoimmune inflammatory disease. The development of low molecular weight kinase inhibitors targeting Jak and Syk appears to be successful for the treatment of rheumatoid arthritis, a representative inflammatory disease. These inhibitors also succeed to regulate joint destruction. On the other hand, calcineurin inhibitors such as tacrolimus and vitamin D are also effective for immune regulation as well as bone metabolism through the inhibition of nuclear factors. Taken together, regulation of cellular signals functioning on immunity as well as bone metabolism may have a potential to approach to the treatment of osteo-immune diseases.

Для цитирования: Tanaka Yoshiya. [Progress in the treatment targeting intracellular signaling in the context of osteoimmunology].. Clinical calcium. 2012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.